Skip to main content
Permissions & Reprints
Begin Print Subscription
Renew Print Subscription
CLI Global Society
Clinical Case Update
Cath Lab Live
Morton Kern, MD
Rebecca Kapur, Managing Editor, Cath Lab Digest
HMP Communications, 70 E. Swedesford Rd
Suite 100, Malvern PA 19355
Telephone: (440) 717-0418
Fax: (866) 896-8762
Volume 26 Issue 10
The FY2019 Reimbursement Impact in the Cath Lab
The following summary provides a high-level look at the upcoming fiscal year (FY) 2019 changes in terms of financial and quality standards.
Retrograde Tibio-Pedal Access for Revascularization of Lower-Extremity Peripheral Artery Disease Using a 6 Fr Slender Sheath: The “Pedal-First” Pilot Project
This is a single-center prospective review of a database of patients who underwent endovascular intervention of their PAD with an attempted pedal-first approach by a single operator.
Aorta to RV Fistula: A Rare Complication of TAVR
Our case illustrates a rare complication of an aorto-RV fistula that did not require repair.
News: Data Presented at TCT 2018 Shows Use of Impella and Best Practices Increases Cardiogenic Shock Survival
“This real-world evidence shows an unprecedented increase in survival outcomes for AMI cardiogenic shock patients and is a result of the increased adoption of best practices for treating cardiogenic shock,” said Dr. O’Neill.
News: Boston Scientific Receives U.S. FDA Approval for the Eluvia Drug-Eluting Vascular Stent System
The FDA’s approval is based on findings from the IMPERIAL trial, in which the Eluvia stent demonstrated superior results in the first superficial femoral artery head-to-head drug-eluting stent trial.
News: COAPT Trial Shows Treatment With MitraClip is Superior to Medical Therapy for Advanced Heart Failure Patients with Significant Secondary Mitral Regurgitation
The COAPT trial met both the primary safety and efficacy endpoints and all secondary endpoints, including reducing all-cause mortality through two years.
Back to Top